UPDATED Jun 03, 2025
Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
RVMD | US$40.58 | 9.7% | 2.0% | US$7.6b | US$72.36 | PB3.6x | E28.7% | n/a | ||
CORT | US$69.51 | -10.5% | 101.8% | US$7.4b | US$138.25 | PE55.6x | E42.2% | n/a | ||
HALO | US$53.31 | -2.0% | 20.3% | US$6.9b | US$67.00 | PE13.5x | E14.8% | n/a | ||
BBIO | US$37.52 | 13.4% | 38.3% | US$6.7b | US$58.78 | PS55.9x | E64.2% | n/a | ||
JAZZ | US$110.32 | 0.8% | 5.6% | US$6.7b | US$184.88 | PE14.1x | E32.5% | n/a | ||
ELAN | US$13.46 | 2.1% | -26.0% | US$6.7b | US$14.55 | PE17.9x | E-2.6% | n/a | ||
RGEN | US$124.40 | 1.5% | -15.8% | US$6.7b | US$183.13 | PS10.7x | E44.6% | n/a | ||
CRL | US$138.49 | -0.1% | -34.1% | US$6.6b | US$158.94 | PS1.7x | E33.4% | n/a | ||
BIO | US$220.57 | -4.2% | -23.5% | US$6.1b | US$318.67 | PS2.4x | E64.1% | n/a | ||
MDGL | US$284.41 | 4.7% | 16.4% | US$6.1b | US$423.14 | PS19.9x | E64.7% | n/a | ||
STVN | US$21.79 | -4.6% | 14.6% | US$6.0b | US$27.35 | PE41.7x | E18.9% | 0.3% | ||
BRKR | US$37.40 | 0.7% | -41.3% | US$5.6b | US$55.13 | PE71.2x | E45.5% | 0.5% | ||
NUVL | US$78.18 | 8.2% | 11.2% | US$5.5b | US$111.70 | PB5.6x | E37.6% | n/a | ||
IONS | US$34.76 | 4.3% | -13.2% | US$5.4b | US$57.54 | PS7.7x | E49.1% | n/a | ||
LEGN | US$28.43 | -1.1% | -31.2% | US$5.4b | US$76.42 | PS7.2x | E58.0% | n/a | ||
AXSM | US$110.11 | 5.9% | 52.4% | US$5.3b | US$177.00 | PS12.6x | E63.4% | n/a | ||
TGTX | US$36.41 | 3.3% | 124.6% | US$5.2b | US$41.20 | PE135.6x | E38.8% | n/a | ||
ALKS | US$31.27 | 4.6% | 32.2% | US$5.2b | US$39.93 | PE14.5x | E-3.5% | n/a | ||
ADMA | US$20.46 | 2.9% | 102.8% | US$4.9b | US$29.49 | PE23.6x | E20.8% | n/a | ||
PCVX | US$34.65 | 9.2% | -51.2% | US$4.5b | US$125.75 | PB1.4x | E30.6% | n/a | ||
PBH | US$84.87 | -1.2% | 32.1% | US$4.2b | US$88.50 | PE19.5x | E4.4% | n/a | ||
MRUS | US$62.42 | 22.9% | 23.9% | US$4.1b | US$89.21 | PS78.9x | E41.6% | n/a | ||
RYTM | US$65.67 | 11.0% | 70.2% | US$4.1b | US$83.42 | PS30.5x | E65.5% | n/a | ||
AKRO | US$51.61 | 12.2% | 168.5% | US$4.0b | US$76.30 | PB3.8x | E-4.9% | n/a |